Exhibit 10.3
SECURITIES PURCHASE
AGREEMENT
THIS SECURITIES PURCHASE AGREEMENT
is made as of the 14 th
day of May, 2009 by and
between XShares Group, Inc., a Delaware corporation (the
“ Company ”), and MGT Capital
Investments, Inc., a Delaware corporation, (the “
Purchaser ”).
The parties hereby agree as
follows:
1.
Purchase and
Sale of Note and Preferred Stock .
1.1.
Issuance of Convertible
Promissory Note .
(a)
The Board of
Directors has duly approved the issuance of the Convertible
Promissory Note (the “ Note ”), in the original
principal amount of $1,100,000, made by the Company in favor of the
Purchaser in the form annexed hereto as Exhibit A.
(b)
Subject to the
terms and conditions of this Agreement, the Purchaser agrees to
purchase the Note immediately upon execution of this Agreement, and
the Company agrees to execute and deliver the Note to the Purchaser
immediately upon receipt from the Purchaser of
$1,000,000.
1.2.
Sale and Issuance of
Series B Preferred Stock .
(a)
The Board of
Directors has duly adopted and approved and submitted to the
shareholders of the Company for their adoption and approval, the
Second Amended and Restated Certificate of Incorporation attached
to this Agreement as Exhibit B (the “
Certificate ”). Upon due
approval of the Certificate by the shareholders of the Company, the
Company shall file the Certificate with the Secretary of State of
the State of Delaware
(b)
Subject to the
terms and conditions of this Agreement, the Purchaser agrees to
purchase at the Closings (as defined below) and the Company agrees
to sell and issue to the Purchaser at the Closings that number of
shares of Series B Preferred Stock, $.0001 par value per share
(the “Series B
Preferred Stock ”), set forth in
Section 1.3(a) below, at a purchase price of $0.0284 per
share. The shares of Series B Preferred Stock issued to
the Purchaser pursuant to this Agreement shall be referred to in
this Agreement as the “ Shares ” (and together with
the Note, the “ Purchased Securities ”).
1.3.
Closing; Delivery
.
(a)
Subject to the
compliance with the conditions set forth in Section 4 and 5,
the initial purchase and sale of
38,732,394 Shares shall take place immediately upon filing of the
Certificate with the Secretary of State of the State of Delaware
(the “ Initial
Closing ”).
(b)
Subject to the
compliance with the conditions set forth in Section 4 and 5,
the second purchase and sale of 35,211,268 Shares shall take place
at the offices of Gersten Savage LLP, 600 Lexington Avenue, New
York, New York via the exchange of documents and signatures, at
11:00 a.m, New York time, on the later of (i) July 16,
2009 or (ii) five days following the filing of the Certificate
with the Secretary of State of the State of Delaware, or at such
other time and place as the Company and the Purchaser mutually
agree upon, in writing (the “Subsequent Closing”);
provided, however , that the Purchaser, in addition to any
other rights of Purchaser set forth herein, shall have no
obligation to purchases the Shares pursuant to this
Section 1.3(b) unless the Purchaser has determined, in
its sole discretion, prior to such investment, that the Company has
been operating the Company’s business in accordance with the
budget attached hereto as Exhibit C (the “
Budget ”), which Budget has
been
approved by the
Company and the Purchaser as of the date of this Agreement
(the Initial Closing and the Subsequent Closing shall be
collectively referred to herein as the
“Closings.”)
(c)
At each Closing,
the Company shall deliver to the Purchaser a certificate
representing the Shares being purchased by the Purchaser at such
Closing against payment of the purchase price therefor by wire
transfer to a bank account designated by the Company, by
cancellation or conversion of indebtedness of the Company to
Purchaser, or by any combination of such methods. Without
limiting the generality of the foregoing, at the Initial Closing,
the Purchaser shall deliver the original Note as consideration for
the Shares issued at the Initial Closing.
1.4
Use of Proceeds
. In accordance with the
directions of the Company’s Board of Directors, the Company
will use the proceeds from the sale of the Shares as set forth in
the Budget.
1.5
Defined Terms Used in this
Agreement . In
addition to the terms defined above, the following terms used in
this Agreement shall be construed to have the meanings set forth or
referenced below.
“ Affiliate ”
means, with respect to any specified Person, any Person, directly
or indirectly, through one or more intermediaries controlling,
controlled by or under common control with such Person.
“ Bylaws ” means
the Bylaws of the Company in the form provided to the
Purchaser.
“ Code ” means
the Internal Revenue Code of 1986, as amended.
“ Company Intellectual
Property ” means all patents, patent applications,
trademarks, trademark applications, service marks, tradenames,
copyrights, trade secrets, domain names, mask works, information
and proprietary rights and processes, licenses in to and under any
of the foregoing, that are owned by the Company or used by the
Company in the conduct of the Company’s business as now
conducted and as presently proposed to be conducted.
“ ETF ” means any
of the Company’s exchange-traded funds.
“ Material Adverse
Effect ” means any occurrence, state of facts, change,
event, effect or circumstance that, individually or in the
aggregate, has, or would reasonably be expected to have, a material
adverse effect on the assets, liabilities, business, results of
operations or financial condition of the Company, including,
without limitation, the Company’s insolvency or a force
majeure event, other than any occurrence, state of facts, change,
event, effect or circumstance to the extent resulting from:
(i) the announcement of the execution of this Agreement, or
(ii) any change in United States generally accepted accounting
principles (“ GAAP ”) or interpretation thereof
after the date hereof or (iii) the execution and performance
of or compliance with this Agreement.
“Person”
means an individual, a partnership,
a joint venture, a corporation, a limited liability company, a
trust, an association, an unincorporated organization, Governmental
Authority and any other entity.
“ Securities Act
” means the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder.
“ Shares ” means
the shares of Series B Preferred Stock issued at the Initial
Closing and at the Subsequent Closing, if any.
2
2.
Representations and Warranties of
the Company . The
Company hereby represents and warrants to each Purchaser that,
except as set forth on the Disclosure Schedule attached as
Exhibit F to this Agreement, which exceptions shall be
deemed to be part of the representations and warranties made
hereunder, the following representations are true and complete as
of the date hereof, except as otherwise indicated. The
Disclosure Schedule shall be arranged in sections corresponding to
the numbered and lettered sections and subsections contained in
this Section 2 , and the disclosures in any section or
subsection of the Disclosure Schedule shall qualify other sections
and subsections in this Section 2 only to the extent it
is readily apparent from a reading of the disclosure that such
disclosure is applicable to such other sections and
subsections.
2.1.
Organization, Good Standing,
Corporate Power and Qualification . Each of the Company, the ETFs, and the
Company Subsidiaries is a corporation or limited liability company
duly organized, validly existing and in good standing under the
laws of the jurisdiction of its organization and has all requisite
corporate power and authority to own, lease and operate its
properties and to carry on its business as now being
conducted. As set forth in Schedule 2.1 , each of the
Company, the ETFs, and the Company Subsidiaries is duly qualified
or licensed and in good standing to do business in each
jurisdiction in which the character of the property owned, leased
or operated by it or the nature of the business conducted by it
makes such qualification or licensing necessary, except where the
failure to be so duly qualified or licensed and in good standing
would not reasonably be expected to have a Material Adverse
Effect. The Company has heretofore made available to
Purchaser accurate and complete copies of the Company’s, each
ETFs, and each Company Subsidiaries’ certificate of
incorporation, by-laws, operating agreements and the equivalent
organizational documents of each of the Company Subsidiaries, each
as currently in effect. None of the Company, any ETF or any
Company Subsidiary is in violation of any provision of its
respective certificate of incorporation, by-laws or equivalent
organizational documents as the case may be.
2.2
.
Capitalization
. The authorized
capital of the Company shall consist, immediately prior to the
Initial Closing, of:
(i)
1,400,000,000
shares of common stock, $0.0001 par value per share (the
“ Common Stock
”),
293,994 shares of which are issued and outstanding.
(ii)
672,000,000
shares of preferred stock, $0.0001 par value per share (the
“ Preferred
Stock ”) (the Common Stock
and the Preferred Stock are collectively referred to as the
“ Securities
”):
(i) 172,000,000 of which have been designated Series A
Preferred Stock, 162,257,593 shares of which are issued and
outstanding; and (ii) 500,000,000 of which have been
designated Series B Preferred Stock, none of which is issued
or outstanding. The rights, privileges and preferences of the
Preferred Stock are as stated in the Certificate and as provided by
the general corporation law of the jurisdiction of the
Company’s incorporation.
(b)
All of the
outstanding securities issued by the Company have been duly
authorized, are fully paid and nonassessable and were issued in
compliance with all applicable federal and state securities
laws. The Company holds no treasury stock.
(c)
Other than
(X) the Note and (Y) as otherwise set forth in the
Disclosure Schedule or on the capitalization table attached hereto
as Exhibit D , there are no (i) outstanding
options, warrants, puts, calls, convertible securities, preemptive
or similar rights, (ii) bonds, debentures, notes or other
indebtedness having general voting rights or that are convertible
or exchangeable into securities having such rights, or
(iii) subscriptions or other rights, agreements, arrangements,
contracts or commitments of any character, relating to the issued
or unissued securities of the Company or any of the
3
Company
Subsidiaries or obligating the Company or any of the Company
Subsidiaries to issue, transfer, deliver or sell or cause to be
issued, transferred, delivered, sold or repurchased any options ,
or other equity interest in, the Company or any of the Company
Subsidiaries or securities convertible into or exchangeable for
such shares or equity interests, or obligating the Company or any
of the Company Subsidiaries to grant, extend or enter into any such
option, warrant, call, subscription or other right, agreement,
arrangement or commitment for such equity interest. There are
no outstanding obligations of the Company or any of the Company
Subsidiaries to repurchase, redeem or otherwise acquire any capital
stock of, or other equity interests in, the Company or any of the
Company Subsidiaries or to provide funds to make any investment (in
the form of a loan, capital contribution or otherwise) in any other
entity.
(d)
To the
Company’s knowledge, there are no stockholders or members
agreements, voting trusts or other agreements or understandings
with respect to the voting of the Securities or the capital stock
or equity interests of any Company Subsidiary.
(e)
The Company has
agreed to reserve 19,000,000 shares of Common Stock for issuance to
officers, directors, employees and consultants of the Company
pursuant to a 2008 Stock Option Plan, as amended (the
“ Stock Plan
”). Of such
reserved shares of Common Stock, no shares have been issued
pursuant to restricted stock purchase agreements, and no options to
purchase shares have been granted to officers, directors, employees
and consultants pursuant to the Stock Plan. The Company has
furnished to the Purchaser complete and accurate copies of the
proposed Stock Plan and forms of agreements used
thereunder.
(f)
A true, complete
and correct copy of the Company’s capitalization table as of
the date hereof is attached hereto as Exhibit D
.
2.3.
Authorization
. All corporate action
required to be taken by the Company’s Board of Directors and
stockholders in order to authorize the Company to enter into this
Agreement, and to issue the Shares at the Closing and the Common
Stock issuable upon conversion of the Shares, has been taken or
will be taken prior to the Initial Closing. All action on the
part of the officers of the Company necessary for the execution and
delivery of this Agreement, the performance of all obligations of
the Company hereunder to be performed as of the Initial Closing,
and the issuance and delivery of the Shares has been taken or will
be taken prior to the Initial Closing. This Agreement, when
executed and delivered by the Company, shall constitute valid and
legally binding obligations of the Company, enforceable against the
Company in accordance with its terms except (i) as limited by
applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance, or other laws of general application
relating to or affecting the enforcement of creditors’ rights
generally, and (ii) as limited by laws relating to the
availability of specific performance, injunctive relief, or other
equitable remedies.
2.4.
Valid Issuance of Purchased
Securities . The
Purchased Securities, when issued, sold and delivered in accordance
with the terms and for the consideration set forth in this
Agreement, will be validly issued, fully paid and nonassessable and
free of restrictions on transfer other than restrictions on
transfer under applicable state and federal securities laws and
liens or encumbrances created by or imposed by the Purchaser.
Assuming the accuracy of the representations of the Purchaser in
Section 3 of this Agreement and subject to the filings
described in Section 2.5(ii) below, the Shares
will be issued in compliance with all applicable federal and state
securities laws. The Common Stock issuable upon conversion of
the Shares has been duly reserved for issuance, and upon issuance
in accordance with the terms of the Certificate, will be validly
issued, fully paid and nonassessable and free of restrictions on
transfer other than restrictions on transfer under applicable
federal and state securities laws and liens or encumbrances created
by or imposed by the Purchaser. Based in part upon the
representations of the Purchaser in Section 3 of this
Agreement, and subject to Section 2.5 below, the Common
Stock issuable
4
upon conversion of the Shares will
be issued in compliance with all applicable federal and state
securities laws.
2.5.
Governmental Consents and
Filings . Assuming
the accuracy of the representations made by the Purchaser in
Section 3 of this Agreement, no consent, approval,
waiver, authorization or permit of, or notice to or declaration or
filing with (each, a “ Consent ”), any nation or
government, any state or other political subdivision thereof, any
entity, authority or body exercising executive, legislative,
judicial, regulatory or administrative functions of or pertaining
to government, including any governmental or regulatory authority,
agency, department, board, commission, administration or
instrumentality, any court, tribunal or arbitrator or any
self-regulatory organization (each, a “ Governmental
Authority ”), on the part of the Company, ETF or any of
the Company Subsidiaries is required to be obtained or made in
connection with the execution, delivery or performance by the
Company of this Agreement or the consummation by the Company of the
transactions contemplated hereby, other than (i) the filing of
the Certificate, which will have been filed as of the Initial
Closing, and (ii) filings pursuant to Regulation D of the
Securities Act, and applicable state securities laws, which have
been made or will be made in a timely manner.
2.6.
Litigation
. Except as set forth in the
Disclosure Schedule, there is no claim, action, suit, proceeding,
arbitration, complaint, charge or, investigation pending or to the
knowledge of the Company, threatened against the Company. The
Company is not a party nor is named as subject to the provisions of
any order, writ, injunction, judgment or decree of any court or
government agency or instrumentality. There is no action,
suit, proceeding or investigation by the Company pending or which
the Company intends to initiate. The foregoing includes,
without limitation, actions, suits, proceedings or investigations
pending or threatened (or any basis therefor known to the Company)
involving the current or prior employment of or engagement of any
of the Company’s employees or consultants, their services
provided in connection with the Company’s business, or any
information or techniques allegedly proprietary to any of their
former employers, or their obligations under any agreements with
prior employers.
2.7.
Compliance with Other
Instruments . The
Company is not in violation or default (i) of any provisions
of its Certificate or Bylaws, (ii) of any instrument,
judgment, order, writ or decree, (iii) under any note,
indenture or mortgage, or (iv) under any lease, agreement,
contract or purchase order to which it is a party or by which it is
bound or, of any provision of federal or state statute,
rule or regulation applicable to the Company, the violation of
which would have a Material Adverse Effect. The execution,
delivery and performance of this Agreement and the consummation of
the transactions contemplated hereby will not result in any such
violation or be in conflict with or constitute, with or without the
passage of time and giving of notice, either (i) a default
under any such provision, instrument, judgment, order, writ,
decree, note, indenture, mortgage, lease, agreement, contract or
purchase order or (ii) an event which results in the creation
of any lien, charge or encumbrance upon any assets of the Company
or the suspension, revocation, forfeiture, or nonrenewal of any
permit or license applicable to the Company.
5
2.8.
Agreements;
Actions . Except for the Convertible
Note and this Agreement, there are no agreements, understandings,
instruments, contracts or proposed transactions to which the
Company is a party or by which it is bound that involve
(i) obligations (contingent or otherwise) of, or payments to,
the Company in excess of $50,000, (ii) the license of any
patent, copyright, trademark, trade secret or other proprietary
right to or from the Company, (iii) the grant of rights to
license, market, or sell its products to any other Person that
limit the Company’s exclusive right to develop, market or
sell its products, or (iv) indemnification by the Company with
respect to infringements of proprietary rights.
(b)
The Company has
not (i) declared or paid any dividends, or authorized or made
any distribution upon or with respect to any class or series of its
capital stock, (ii) incurred any indebtedness for money
borrowed or incurred any other liabilities individually in excess
of $50,000 or in excess of $100,000 in the aggregate,
(iii) except as listed on Schedule 2.8(b)(iii), made
any loans or advances to any Person, other than ordinary advances
for travel expenses, or (iv) sold, exchanged or otherwise
disposed of any of its assets or rights.
(c)
The Company is
not a guarantor or indemnitor of any indebtedness of any other
Person.
(d)
The Company has
not engaged in the past twelve (12) months in any discussion with
any representative of any Person (other than the Purchaser)
regarding (i) a sale or exclusive license of all or
substantially all of the Company’s assets, or (ii) any
merger, consolidation or other business combination transaction of
the Company with or into another Person.
2.9.
Certain Transactions
. Except as listed on
Schedule 2.9 , the Company is not indebted, directly or
indirectly, to any of its directors, officers or employees or to
their respective spouses or children or to any Affiliate of any of
the foregoing, other than in connection with expenses or advances
of expenses incurred in the ordinary course of business or employee
relocation expenses and for other customary employee benefits made
generally available to all employees. None of the
Company’s directors, officers or employees, or any members of
their immediate families, or any Affiliate of the foregoing are,
directly or indirectly, indebted to the Company.
2.10.
Absence of Liens
. The property and assets that
the Company owns are free and clear of all mortgages, deeds of
trust, liens, loans and encumbrances, except for statutory liens
for the payment of current taxes that are not yet delinquent.
With respect to the property and assets it leases, the Company is
in compliance with such leases and, to its knowledge, except as
listed on Schedule 2.10 , holds a valid leasehold interest
free of any liens, claims or encumbrances other than those of the
lessors of such property or assets. With respect to each such
Company lease, no lessor, lien, claim, or encumbrance interferes
with the Company’s use and quiet enjoyment of such leased
property or asset.
2.11.
Financial Statements
. The Company has delivered to
the Purchaser its audited financial statements (including balance
sheet, income statement and statement of cash flows) as of
December 31, 2007 and December 31, 2008 and unaudited
financial statements for the three-month period ended
March 31, 2009 (collectively, the “ Financial
Statements ”). The Financial Statements have been
prepared in accordance with generally accepted accounting
principles applied on a consistent basis throughout the periods
indicated, except that the unaudited Financial Statements may not
contain all footnotes required by generally accepted accounting
principles. The Financial Statements fairly present in all
material respects the financial condition and operating results of
the Company as of the dates, and for the periods, indicated
therein, subject in the case of the unaudited Financial Statements
to normal year-end audit adjustments, which are not material.
Except as set forth in the Financial Statements, the Company has no
liabilities or obligations, contingent or otherwise, other than
(i) liabilities incurred in the
6
ordinary course of business
subsequent to March 31, 2009 and which have been disclosed to
the Company in writing (ii) obligations under contracts and
commitments incurred in the ordinary course of business and which
have been disclosed to the Company in writing and
(iii) liabilities and obligations of a type or nature not
required under generally accepted accounting principles to be
reflected in the Financial Statements, which, in all such cases,
individually and in the aggregate would not have a Material Adverse
Effect. The Company maintains and will continue to maintain a
standard system of accounting established and administered in
accordance with generally accepted accounting
principles.
2.12.
Changes . Since the date of the most recent
Financial Statements, other than the Convertible Note, there has
not been:
(a)
any change in the
assets, liabilities, financial condition or operating results of
the Company from that reflected in the Financial Statements, except
changes in the ordinary course of business that have not caused, in
the aggregate, a Material Adverse Effect;
(b)
any damage,
destruction or loss, whether or not covered by insurance, that
would have a Material Adverse Effect;
(c)
any waiver or
compromise by the Company of a valuable right or of a material debt
(in excess of $10,000) owed to it;
(d)
any satisfaction
or discharge of any lien, claim, or encumbrance or payment of any
obligation by the Company, except in the ordinary course of
business and the satisfaction or discharge of which would not have
a Material Adverse Effect;
(e)
any material
change to a material contract or agreement (in excess of $10,000)
by which the Company or any of its assets is bound or
subject;
(f)
any change in any
compensation arrangement or agreement with any employee, officer,
director or stockholder;
(g)
any resignation
or termination of employment of any officer, employee, or
consultant of the Company;
(h)
any mortgage,
pledge, transfer of a security interest in, or lien, created by the
Company, with respect to any of its material properties or assets
(in excess of $10,000), except liens for taxes not yet due or
payable and liens that arise in the ordinary course of business and
do not impair the Company’s ownership or use of such property
or assets;
(i)
any loans or
guarantees made by the Company to or for the benefit of its
employees, officers directors or consultants, or any members of
their immediate families,;
(j)
any declaration,
setting aside or payment or other distribution in respect of any of
the Company’s capital stock, or any direct or indirect
redemption, purchase, or other acquisition of any of such stock by
the Company;
(k)
any sale,
assignment or transfer of any Company Intellectual Property that
could reasonably be expected to result in a Material Adverse
Effect;
(l)
receipt of notice
that there has been a loss of, or material order cancellation by,
any major customer of the Company;
7
(m)
any other event
or condition of any character, other than events affecting the
economy or the Company’s industry generally,
that could
reasonably be expected to result in a Material Adverse Effect;
or
(n)
any arrangement
or commitment by the Company to do any of the things described in
this Section 2.12 .
2.13.
Tax Returns and
Payments . The
Company has timely paid all federal, state, county, local or
foreign taxes due and payable. There are no accrued and
unpaid federal, state, county, local or foreign taxes of the
Company which are due, whether or not assessed or disputed.
There have been no examinations or audits of any tax returns or
reports by any applicable federal, state, local or foreign
governmental agency. The Company has duly and timely filed
all federal, state, county, local and foreign tax returns required
to have been filed by it and there are in effect no waivers of
applicable statutes of limitations with respect to taxes for any
year. The Company has properly withheld and paid all taxes
required to have been withheld and paid in connection with any
amounts paid or credited to any employee, independent contractor,
creditor, stockholder or other third party.
2.14.
Insurance . The Company, each ETF, and each Company
Subsidiary is covered by valid and currently effective insurance
policies issued in favor of the Company or one or more of the ETFs
or Company Subsidiaries that are customary for companies of similar
size in the industry and locales in which the Company and the
Company Subsidiaries operate. Schedule 2.14 sets forth
a true, correct and complete list of all insurance policies issued
in favor of the Company, any ETF, or any Company Subsidiary, or
pursuant to which the Company, any ETF, or any Company Subsidiary
is a named insured or otherwise a beneficiary, as well as any
historic incurrence-based policies still in force. With
respect to each such insurance policy, (i) the policy is in
full force and effect and all premiums due thereon have been paid,
(ii) neither the Company or any ETF, nor any Company
Subsidiary is in any material respect, in breach of or default
under, and neither the Company or any ETF, nor any Company
Subsidiary have taken any action or failed to take any action
which, with notice or the lapse of time or both, would constitute
such a breach or default, or permit termination or modification of,
any such policy, (iii) to the knowledge of the Company, no
insurer on any such policy has been declared insolvent or placed in
receivership, conservatorship or liquidation, and no notice of
cancellation or termination has been received with respect to any
such policy, and (iv) the Company knows of no reason any
such insurance policy would be cancelled or modified in any
material respect as a result of the transactions contemplated
hereby.
2.15.
Regulatory Agreements;
Permits .
(a)
There are no (A) written
agreements, consent agreements, memoranda of understanding,
commitment letters, cease and desist orders, or similar
undertakings to which the Company, any ETF, or any Company
Subsidiary is a party, on the one hand, and any Governmental
Authority is a party or addressee, on the other hand, (B ) Orders
or directives of or supervisory letters from a Governmental
Authority specifically with respect to the Company, any ETF, or any
Company Subsidiary, or (C) resolutions or policies or
procedures adopted by the Company, any ETF, or any Company
Subsidiary at the request of a Governmental Authority, that
(1) limit in any respect the ability of the Company, any
ETF, or any of the Company Subsidiaries to conduct its business as
currently being conducted or (2) in any manner relate to the
ability of the Company, any ETF, or any of the Company
Subsidiaries to pay dividends or otherwise restrict the conduct of
business of the Company, any ETF, or any of the Company
Subsidiaries in any respect.
8
(b)
The Company, the ETFs, and the
Company Subsidiaries hold all permits, licenses, franchises,
grants, authorizations, consents, exceptions, variances,
exemptions, orders and other governmental authorizations,
certificates, consents and approvals necessary to lawfully conduct
their businesses as presently conducted and contemplated to be
conducted, and to own, lease and operate their assets and
properties (collectively, the “ Company Permits
”), all of which are in full force and effect, and no
suspension or cancellation of any of the Company Permits is pending
or, to the knowledge of the Company, threatened,. Schedule
2.15(a) sets forth each Company Permit. Each of the
Company, the ETFs, and the Company Subsidiaries are not in
violation in any material respect of the terms of any Company
Permit.
(c)
No investigation, review or market
conduct examination by any Governmental Authority with respect to
the Company, any ETF, or any Company Subsidiary is pending or, to
the knowledge of the Company, threatened, nor does the Company have
knowledge of any Governmental Authority’s intention to
conduct any such investigation or review.
(d)
Each of the Company, each ETF, and
each Company Subsidiary and each of their respective officers and
employees who are required to be registered, licensed or qualified
as (A) an investment company, broker-dealer, investment
adviser, futures commission merchant or (B) a registered
principal, registered representative, investment adviser
representative, insurance agent or salesperson with the SEC or any
securities or insurance commission or other Governmental Authority
are duly registered as such and such registrations are in full
force and effect, or are in the process of being registered as such
within the time periods required by applicable law, except in each
case for any failures to be so registered, licensed or qualified
that would not reasonably be expected, individually or in the
aggregate, to have a Material Adverse Effect. Each of the Company,
each ETF, and each Company Subsidiary and each of their respective
officers and employees are in compliance with all applicable
federal, state and foreign laws requiring any such registration,
licensing or qualification, and are not subject to any liability or
disability by reason of the failure to be so registered, licensed
or qualified, except as would not reasonably be expected,
individually or in the aggregate, to have a Material Adverse
Effect.
(e)
Each of the Company, each ETF, and
each Company Subsidiary, and, to the knowledge of the Company, its
solicitors, third party administrators, managers, brokers and
distributors, have marketed, sold and issued investment products
and securities in compliance with all applicable laws governing
sales processes and practices, except in each case as would not
reasonably be e
|